Shares of Syngene International were trading at Rs 655, a marginal decrease of 0.34% in Wednesday's session amid volume surge. The stock is a constituent of the Nifty Midcap 150 index.
Financial Snapshot:
Consolidated Quarterly Performance:
Key financial figures for Syngene International on a consolidated basis are as follows:
Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|
Revenue | Rs 789.70 Crore | Rs 891.00 Crore | Rs 943.70 Crore | Rs 1,018.00 Crore | Rs 874.50 Crore |
Net Profit | Rs 75.70 Crore | Rs 106.10 Crore | Rs 131.10 Crore | Rs 183.30 Crore | Rs 86.70 Crore |
EPS | 1.89 | 2.64 | 3.27 | 4.56 | 2.16 |
Consolidated Yearly Performance:
The yearly financial performance of the company is detailed below:
Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenue | Rs 2,184.30 Crore | Rs 2,604.20 Crore | Rs 3,192.90 Crore | Rs 3,488.60 Crore | Rs 3,642.40 Crore |
Net Profit | Rs 404.90 Crore | Rs 395.80 Crore | Rs 464.40 Crore | Rs 510.00 Crore | Rs 496.20 Crore |
EPS | 10.18 | 9.94 | 11.59 | 12.71 | 12.35 |
BVPS | 70.54 | 82.28 | 90.13 | 105.92 | 117.44 |
ROE | 14.35 | 12.00 | 12.83 | 11.97 | 10.49 |
Debt to Equity | 0.27 | 0.24 | 0.16 | 0.03 | 0.03 |
Annual Income Statement:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Sales | 3,642 | 3,488 | 3,192 | 2,604 | 2,184 |
Other Income | 71 | 90 | 70 | 52 | 64 |
Total Income | 3,714 | 3,579 | 3,263 | 2,657 | 2,248 |
Total Expenditure | 3,001 | 2,911 | 2,625 | 2,148 | 1,752 |
EBIT | 713 | 668 | 638 | 508 | 496 |
Interest | 53 | 47 | 45 | 24 | 27 |
Tax | 163 | 110 | 129 | 88 | 64 |
Net Profit | 496 | 510 | 464 | 395 | 404 |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
---|---|---|---|---|---|
Sales | 874 | 1,018 | 943 | 891 | 789 |
Other Income | 17 | 18 | 18 | 16 | 18 |
Total Income | 892 | 1,036 | 962 | 907 | 807 |
Total Expenditure | 779 | 780 | 768 | 757 | 694 |
EBIT | 112 | 256 | 193 | 150 | 113 |
Interest | 11 | 15 | 12 | 13 | 11 |
Tax | 14 | 57 | 49 | 31 | 25 |
Net Profit | 86 | 183 | 131 | 106 | 75 |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Operating Activities | 1,167 | 1,042 | 823 | 580 | 701 |
Investing Activities | -744 | -495 | -656 | -611 | -628 |
Financing Activities | -141 | -551 | -342 | -31 | 58 |
Others | 0 | 1 | 3 | 0 | 0 |
Net Cash Flow | 281 | -3 | -172 | -61 | 130 |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Share Capital | 402 | 402 | 401 | 400 | 400 |
Reserves & Surplus | 4,324 | 3,855 | 3,216 | 2,896 | 2,421 |
Current Liabilities | 1,396 | 1,144 | 1,188 | 1,228 | 1,133 |
Other Liabilities | 672 | 749 | 1,024 | 1,037 | 928 |
Total Liabilities | 6,795 | 6,151 | 5,831 | 5,563 | 4,883 |
Fixed Assets | 4,067 | 3,688 | 2,843 | 2,739 | 2,438 |
Current Assets | 2,287 | 1,959 | 2,425 | 2,205 | 1,806 |
Other Assets | 440 | 504 | 561 | 618 | 638 |
Total Assets | 6,795 | 6,151 | 5,831 | 5,563 | 4,883 |
Contingent Liabilities | 804 | 837 | 805 | 664 | 595 |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Basic EPS (Rs.) | 12.35 | 12.71 | 11.59 | 9.94 | 10.18 |
Diluted Eps (Rs.) | 12.34 | 12.69 | 11.51 | 9.82 | 10.11 |
Book Value /Share (Rs.) | 117.44 | 105.92 | 90.13 | 82.28 | 70.54 |
Dividend/Share (Rs.) | 1.25 | 1.25 | 0.50 | 1.00 | 0.00 |
Face Value | 10 | 10 | 10 | 10 | 10 |
Gross Profit Margin (%) | 30.57 | 31.67 | 31.48 | 32.59 | 33.71 |
Operating Margin (%) | 18.69 | 19.46 | 20.00 | 20.70 | 21.14 |
Net Profit Margin (%) | 13.62 | 14.61 | 14.54 | 15.19 | 18.53 |
Return on Networth (%) | 10.49 | 11.97 | 12.83 | 12.00 | 14.35 |
ROCE (%) | 12.61 | 13.56 | 13.75 | 12.43 | 12.31 |
Return On Assets (%) | 7.30 | 8.29 | 7.96 | 7.11 | 8.29 |
Current Ratio (X) | 1.64 | 1.71 | 2.04 | 1.80 | 1.59 |
Quick Ratio (X) | 1.53 | 1.50 | 1.76 | 1.65 | 1.54 |
Debt to Equity (x) | 0.03 | 0.03 | 0.16 | 0.24 | 0.27 |
Interest Coverage (X) | 20.97 | 23.41 | 22.24 | 35.22 | 26.58 |
Asset Turnover Ratio (%) | 0.56 | 0.58 | 0.56 | 0.50 | 0.48 |
Inventory Turnover Ratio (X) | 4.70 | 3.06 | 3.52 | 6.45 | 13.01 |
3 Yr CAGR Sales (%) | 18.27 | 26.38 | 25.98 | 19.44 | 23.89 |
3 Yr CAGR Net Profit (%) | 11.97 | 12.23 | 6.16 | 9.25 | 15.14 |
P/E (x) | 58.80 | 55.28 | 51.29 | 60.12 | 53.38 |
P/B (x) | 6.18 | 6.63 | 6.60 | 7.25 | 7.70 |
EV/EBITDA (x) | 25.64 | 25.15 | 23.78 | 28.50 | 29.69 |
P/S (x) | 8.02 | 8.09 | 7.47 | 9.19 | 9.95 |
Syngene International announced a final dividend of Rs 1.25 per share (12.5%) on April 23, 2025, with an effective date of June 27, 2025. A bonus issue of 1:1 was announced on April 24, 2019, with the ex-bonus date being June 11, 2019.
The company had an analyst/investor meet intimation on September 12, 2025. An investor presentation was also released on September 9, 2025.
With the stock's last traded price at Rs 655, Syngene International experienced a marginal decrease of 0.34% in today's session amid volume surge.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.